openPR Logo
Press release

Dengue Vaccine Market Size, Share, Growth and Trends, Report 2024-2031

09-16-2024 03:09 PM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

Dengue Vaccine Market || 2024-2031

Dengue Vaccine Market || 2024-2031

The Global Dengue Vaccine Market is estimated to reach at a CAGR of 10.4% during the forecast period (2024-2031).

Dengue is a mosquito-borne illness caused by the dengue virus, which is part of the Flaviviridae family and the Flavivirus genus. Commonly referred to as "breakbone fever" or "dandy fever," dengue primarily spreads from human to human through the bite of an infected Aedes aegypti mosquito.

Get a Free Sample Research PDF - https://www.datamintelligence.com/download-sample/dengue-vaccine-market

Market Dynamics:

Increasing Collaborations by the Research Institutes for the Clinical Trials of the Dengue Vaccine is Expected to Drive Market Growth.

In response to the rising incidence of dengue cases across the country, the Indian Council of Medical Research (ICMR) has initiated efforts to advance the development of a dengue vaccine. The ICMR is encouraging vaccine developers and pharmaceutical companies that have either developed or licensed tetravalent dengue vaccine candidates and have completed Phase I and Phase II clinical trials to collaborate with them for Phase III trials and further vaccine development.

The ICMR will provide institutional infrastructure for research and development (R&D) and Phase III clinical trials to evaluate the efficacy, safety, and immunogenicity of these tetravalent dengue vaccine candidates. For example, on March 4, 2022, the ICMR invited expressions of interest from Indian manufacturers with potential tetravalent vaccine candidates or non-exclusive licenses who are looking to conduct field studies as part of Phase III clinical trials.

This collaboration between vaccine manufacturers and the ICMR is expected to significantly drive the dengue vaccine market in the forecast period.

Segment Covered in Dengue Vaccine Market:

By Product Type: CYD-TDV.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, Others.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/dengue-vaccine-market

Key players involved in Dengue Vaccine Market:

• Sanofi
• Panacea Biotec
• Biological
• E. Limited
• GlaxoSmithKline plc
• Merck & Co.
• Takeda Pharmaceutical Company Ltd
• Vabiotec
• Panacea Biotec
• Medigen Biologics

*Note:

• Additionally, I wanted to highlight that the full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted.

Regional Analysis:

The Dengue Vaccine Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Dengue Vaccine Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Related Reports:

Foam Dressings Market: https://www.datamintelligence.com/research-report/global-foam-dressings-market

Clinical Trials Market: https://www.datamintelligence.com/research-report/clinical-trials-market

Skin Cancer Market: https://www.datamintelligence.com/research-report/skin-cancer-market

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dengue Vaccine Market Size, Share, Growth and Trends, Report 2024-2031 here

News-ID: 3656723 • Views:

More Releases from DataM Intelligence 4Market Research

United States Skin Cancer Drugs Market Set to Surge: Innovative Therapies and Rising Awareness Drive Growth in 2025 | Major key players - Amgen Inc., Sanofi S.A., Novartis AG.
United States Skin Cancer Drugs Market Set to Surge: Innovative Therapies and Ri …
Market Overview: The Skin Cancer Drugs Market is estimated to reach at a CAGR of 10.2% during the forecast period (2024-2031). The Skin Cancer Drugs Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research
United States Aircraft Battery Charger Market is expected to reach US$ 1032.9 Million by 2030 | Top key players - Eaton, Concorde, Fine Art America.
United States Aircraft Battery Charger Market is expected to reach US$ 1032.9 Mi …
Market Size and Forecast: The Global Aircraft Battery Charger Market Size reached US$ 570.5 million in 2022 and is expected to reach US$ 1032.9 million by 2030, growing with a CAGR of 7.9% during the forecast period 2024-2031. The Aircraft Battery Charger Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to
United States Cloud-based Printing Market is expected to reach US$ 3.96 billion by 2032 | Top key players - HP Inc., Canon Inc., Xerox Corporation.
United States Cloud-based Printing Market is expected to reach US$ 3.96 billion …
Market Size and Forecast: The Cloud-based Printing Market Size reached US$1.52 billion in 2024 and is expected to reach US$3.96 billion by 2032, growing with a CAGR of 12.71% during the forecast period 2025-2032. The Cloud-based Printing Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay
United States Beauty Devices for At-Home Laser Treatments Market is expected to reach US$1,302.5 million by 2033 | Top key players - Tria Beauty, NIRA SKIN, DermRays.
United States Beauty Devices for At-Home Laser Treatments Market is expected to …
Market Size and Forecast: The Global Beauty Devices for At-Home Laser Treatments Market Size reached US$537.1 million in 2024 and is expected to reach US$1,302.5 million by 2033, growing at a CAGR of 10.3% during the forecast period 2025-2033. The Beauty Devices for At-Home Laser Treatments Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM

All 5 Releases


More Releases for Dengue

Key Trend Reshaping the Dengue Treatment Market in 2025: Innovative Drug Deliver …
Which drivers are expected to have the greatest impact on the over the dengue treatment market's growth? The escalation in cases of dengue is projected to stimulate the expansion of the market for dengue treatments. Dengue is a viral infection transmitted by mosquito bites, causing symptoms akin to the flu and can escalate to intense complications if not treated. The escalation is primarily due to progressing urbanization, climate alterations favourable to
Key Dengue Vaccine Market Trend for 2025-2034: Advancements In Dengue Tetravalen …
What Is the Future Outlook for the Dengue Vaccine Market's Size and Growth Rate? In the past few years, the dengue vaccine market has experienced significant growth. From $0.64 billion in 2024, it is projected to reach $0.72 billion in 2025, marking a compound annual growth rate (CAGR) of 12.4%. This notable expansion during the historical period can be credited to factors such as an increase in travel and urbanization trends,
Dengue Vaccine Market : An Detailed Overview
Introduction: Dengue fever is a mosquito-borne viral infection caused by the dengue virus, transmitted primarily through Aedes aegypti and Aedes albopictus mosquitoes. Affecting millions globally each year, dengue has become a significant public health concern, especially in tropical and subtropical regions. The development of dengue vaccines represents a groundbreaking advancement in preventing the disease, reducing its associated healthcare costs, and controlling outbreaks. With increasing awareness and investments in immunization programs, the
Dengue Vaccine Market : An Overview
Introduction: Dengue fever is a mosquito-borne viral infection that has become a significant public health challenge in tropical and subtropical regions. The disease is caused by the dengue virus, which is transmitted primarily by Aedes aegypti mosquitoes. With approximately 390 million infections annually, dengue fever places a substantial burden on healthcare systems and economies worldwide. Efforts to mitigate this burden have led to the development of dengue vaccines, designed to prevent
"Rising Incidence of Dengue Fever Propels Dengue Virus Diagnostic Tests Market T …
According to WHO, dengue affects about 50-100 million people worldwide, annually. It is a vector-borne highly communicable disease. This report discusses the diagnostic tests used to confirm the presence of dengue in one individual. It is true that the growth of the global dengue virus diagnostic tests market is primarily driven by an increase in the incidence of dengue fever, which is a mosquito-borne viral infection that can cause severe flu-like
Dengue Vaccines Market 2021 | Detailed Report
Dengue Vaccines Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Dengue Vaccines Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4644240 The report provides a comprehensive analysis of company profiles listed below: - Sanofi - Takeda Dengue Vaccines Market Segment by